Regis Corp. (RGS) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts RGS Hot Sheet
Price: $29.12 --0%
Revenue Growth %: -5.6%
Financial Fact:
Product: 83.48M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: -5.6%
Financial Fact:
Product: 83.48M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Regis Corp. (NYSE: RGS) reported Q2 EPS of ($0.04), $0.05 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $468.4 million versus the consensus estimate of $478.81 million.
Same-store sales declined 6.2%.
For earnings history and earnings-related data on Regis Corp. (RGS) click here.
Same-store sales declined 6.2%.
For earnings history and earnings-related data on Regis Corp. (RGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
- Seres Therapeutics (MCRB) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
Earnings, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
